12-109561046-TCGGCCCGGCGGCACA-TCGGCCCGGCGGCACACGGCCCGGCGGCACA
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PM4PP5_Very_Strong
The NM_052845.4(MMAB):c.563_577dupTGTGCCGCCGGGCCG(p.Val188_Ala192dup) variant causes a conservative inframe insertion change. The variant allele was found at a frequency of 0.0000434 in 1,450,316 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.0000070 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000047 ( 0 hom. )
Consequence
MMAB
NM_052845.4 conservative_inframe_insertion
NM_052845.4 conservative_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.67
Genes affected
MMAB (HGNC:19331): (metabolism of cobalamin associated B) This gene encodes a protein that catalyzes the final step in the conversion of vitamin B(12) into adenosylcobalamin (AdoCbl), a vitamin B12-containing coenzyme for methylmalonyl-CoA mutase. Mutations in the gene are the cause of vitamin B12-dependent methylmalonic aciduria linked to the cblB complementation group. Alternatively spliced transcript variants have been found. [provided by RefSeq, Apr 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_052845.4.
PP5
Variant 12-109561046-T-TCGGCCCGGCGGCACA is Pathogenic according to our data. Variant chr12-109561046-T-TCGGCCCGGCGGCACA is described in ClinVar as [Likely_pathogenic]. Clinvar id is 203822.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMAB | NM_052845.4 | c.563_577dupTGTGCCGCCGGGCCG | p.Val188_Ala192dup | conservative_inframe_insertion | 7/9 | ENST00000545712.7 | NP_443077.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMAB | ENST00000545712.7 | c.563_577dupTGTGCCGCCGGGCCG | p.Val188_Ala192dup | conservative_inframe_insertion | 7/9 | 1 | NM_052845.4 | ENSP00000445920.1 |
Frequencies
GnomAD3 genomes AF: 0.00000701 AC: 1AN: 142732Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
1
AN:
142732
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000805 AC: 2AN: 248548Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134930
GnomAD3 exomes
AF:
AC:
2
AN:
248548
Hom.:
AF XY:
AC XY:
1
AN XY:
134930
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000474 AC: 62AN: 1307584Hom.: 0 Cov.: 36 AF XY: 0.0000432 AC XY: 28AN XY: 648758
GnomAD4 exome
AF:
AC:
62
AN:
1307584
Hom.:
Cov.:
36
AF XY:
AC XY:
28
AN XY:
648758
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000701 AC: 1AN: 142732Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 69060
GnomAD4 genome
AF:
AC:
1
AN:
142732
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
69060
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Methylmalonic aciduria, cblB type Pathogenic:5
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Oct 03, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 09, 2023 | This variant, c.563_577dup, results in the insertion of 5 amino acid(s) of the MMAB protein (p.Val188_Ala192dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs747499304, gnomAD 0.002%). This variant has been observed in individual(s) with clinical features of cobalamin B type methylmalonic aciduria (PMID: 16410054, 22695176; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 203822). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 08, 2024 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Aug 17, 2020 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Baumgartner lab, University Children's Hospital Zurich | Jun 01, 2021 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 18, 2014 | The c.563_577dupTGTGCCGCCGGGCCG, the normal sequence with the bases that are duplicated in braces is: GCCG{TGTGCCGCCGGGCCG}AGAGAC. mutation in the MMAB gene has been reported previously in association with vitamin-B12 responsive methylmalonic acidemia (MMA) in a patient who presented with symptoms at day 7 of life (Lerner-Ellis et al., 2006). Mutation occurs in the active site of the MMAB enzyme (Lerner-Ellis et al., 2006). The c.563_577dupTGTGCCGCCGGGCCG mutation results in a insertion of 5 amino acids, denoted p.Val188_Ala192dup. The variant is found in MMAB panel(s). - |
Methylmalonic acidemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 18, 2021 | Variant summary: MMAB c.563_577dup15 (p.Val188_Ala192dup) results in an in-frame duplication that is predicted to duplicate 5 amino acids in the Cobalamin adenosyltransferase-like domain (IPR016030) of the encoded protein. The variant allele was found at a frequency of 8e-06 in 248548 control chromosomes. c.563_577dup15 has been reported in the literature as a compound heterozygous genotype in multiple individuals affected with Methylmalonic Acidemia (example, Lerner-Ellis_2006, Vatanavicharn_2012). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at